Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review
Open accessThe DOI matches its Crossref record; 895 of the 895 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The randomised controlled trial (RCT) is widely considered to be the gold standard study for comparing the effectiveness of health interventions. Central to the design and validity of a RCT is a calculation of the number of participants needed (the sample size). The value used to determine the sample size can be considered the 'target difference'. From both a scientific and an ethical standpoint, selecting an appropriate target difference is of crucial importance. Determination of the target difference, as opposed to statistical approaches to calculating the sample size, has been greatly neglected though a variety of approaches have been proposed the current state of the evidence is unclear. OBJECTIVES: The aim was to provide an overview of the current evidence regarding specifying the target difference in a RCT sample size calculation. The specific objectives were to conduct a systematic review of methods for specifying a target difference; to evaluate current practice by surveying triallists; to develop guidance on specifying the target difference in a RCT; and to identify future research needs. DESIGN: The biomedical and social science databases searched were MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Methodology Register, PsycINFO, Science Citation Index, EconLit, Education Resources Information Center (ERIC) and Scopus for in-press publications. All were searched from 1966 or the earliest date of the database coverage and searches were undertaken between November 2010 and January 2011. There were three interlinked components: (1) systematic review of methods for specifying a target difference for RCTs - a comprehensive search strategy involving an electronic literature search of biomedical and some non-biomedical databases and clinical trials textbooks was carried out; (2) identification of current trial practice using two surveys of triallists - members of the Society for Clinical Trials (SCT) were invited to complete an online survey and respondents were asked about their awareness and use of, and willingness to recommend, methods; one individual per triallist group [UK Clinical Research Collaboration (UKCRC)-registered Clinical Trials Units (CTUs), Medical Research Council (MRC) UK Hubs for Trials Methodology Research and National Institute for Health Research (NIHR) UK Research Design Services (RDS)] was invited to complete a survey; (3) production of a structured guidance document to aid the design of future trials - the draft guidance was developed utilising the results of the systematic review and surveys by the project steering and advisory groups. SETTING: Methodological review incorporating electronic searches, review of books and guidelines, two surveys of experts (membership of an international society and UK- and Ireland-based triallists) and development of guidance. PARTICIPANTS: The two surveys were sent out to membership of the SCT and UK- and Ireland-based triallists. INTERVENTIONS: The review focused on methods for specifying the target difference in a RCT. It was not restricted to any type of intervention or condition. MAIN OUTCOME MEASURES: Methods for specifying the target difference for a RCT were considered. RESULTS: The search identified 11,485 potentially relevant studies. In total, 1434 were selected for full-text assessment and 777 were included in the review. Seven methods to specify the target difference for a RCT were identified - anchor, distribution, health economic, opinion-seeking, pilot study, review of evidence base (RoEB) and standardised effect size (SES) - each having important variations in implementation. A total of 216 of the included studies used more than one method. A total of 180 (15%) responses to the SCT survey were received, representing 13 countries. Awareness of methods ranged from 38% (n =69) for the health economic method to 90% (n =162) for the pilot study. Of the 61 surveys sent out to UK triallist groups, 34 (56%) responses were received. Awareness ranged from 97% (n =33) for the RoEB and pilot study methods to only 41% (n =14) for the distribution method. Based on the most recent trial, all bar three groups (91%, n =30) used a formal method. Guidance was developed on the use of each method and the reporting of the sample size calculation in a trial protocol and results paper. CONCLUSIONS: There is a clear need for greater use of formal methods to determine the target difference and better reporting of its specification. Raising the standard of RCT sample size calculations and the corresponding reporting of them would aid health professionals, patients, researchers and funders in judging the strength of the evidence and ensuring better use of scarce resources. FUNDING: The Medical Research Council UK and the National Institute for Health Research Joint Methodology Research programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Internal pilot studies were primarily viewed as part of the full trial [8, 32, 35–38] and are therefore not depicted under nomenclature in Table 3.”
From Exploratory studies to decide whether and how to proceed with full-scale evaluations of public health interventions: a systematic review of guidance (2018) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 801–895 of 895
Different methods to assess quality of life from multiple follow-ups in a longitudinal asthma study
Mancuso, C. A., & Peterson, M. G. E. (2004) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00248-8 · Cited by 13
Sample Size in Obesity Trials: Patient Perspective Versus Current Practice
Allison, D. B., Elobeid, M., Cope, M. B., Brock, D. W., Faith, M. S., Veur, S. S. V., Berkowitz, R. I., Cutter, G., McVie, T., Gadde, K. M., et al. (2009) · Medical Decision Making · doi:10.1177/0272989x09340583 · Cited by 13
Coherent scattering and bone mineral measurement: The dependence of sensitivity on angle and energy
Ndlovu, A. M., Farrell, T. J., & Webber, C. E. (1991) · Medical Physics · doi:10.1118/1.596614 · Cited by 13
Hayran, O., Mumcu, G., İnanç, N., Ergun, T., & Di̇reskeneli̇, H. (2009) · PubMed · Cited by 13
Kropmans, T., Dijkstra, P. U., Stegenga, B., Stewart, R. E., & de Bont, L. G. M. (2002) · Clinical Journal of Pain · doi:10.1097/00002508-200203000-00006 · Cited by 13
Parabiaghi, A., Barbato, A., D’Avanzo, B., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2005.01656.x · Cited by 13
Power function arguments in support of an alternative approach for analyzing management trials
Willan, A. R. (1994) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)90058-2 · Cited by 12
Bouffioulx, É., Thonnard, J., Arnould, C., & Vandervelde, L. (2010) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0635 · Cited by 12
Kirby, S., Chuang‐Stein, C., & Morris, M. F. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400903315757 · Cited by 12
Fitzpatrick, C., Simpson, J. M., Valentine, J. D., Ryder, S., Peacock-Edwards, T., Sidnell, P., & Colognese, M. (2005) · Clinical Rehabilitation · doi:10.1191/0269215505cr783oa · Cited by 12
A brief symptom index for advanced renal cell carcinoma
Eton, D. T., Cella, D. F., Bacik, J., & Motzer, R. J. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-68 · Cited by 12
THE MINIMUM CLINICALLY IMPORTANT IMPROVEMENT FOR THE INCREMENTAL SHUTTLE WALKING TEST
Kalra, S., & Roitman, J. L. (2008) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/01.hcr.0000327249.84204.19 · Cited by 12
Taylor, L. N., McGeer, J. C., Wood, C. M., & McDonald, D. G. (2000) · Environmental Toxicology and Chemistry · doi:10.1897/1551-5028(2000)019 · Cited by 12
Spadoni, G. F. (2004) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2004.1157 · Cited by 12
The clinically meaningful change in physical performance scores in an elderly cohort
Nieves, J. W., Li, T. M. W. Y., Zion, M., Gussekloo, J., Pahor, M., Bernabei, R., Simon, H., Williams, G. R., & Lapuerta, P. (2007) · Aging Clinical and Experimental Research · doi:10.1007/bf03324735 · Cited by 11
How can we design trials to detect clinically important changes in disease severity?
Saintonge, C. D. D., Kirwan, J., Evans, S. J. W., & Crane, G. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03392.x · Cited by 11
Roy, K. M., Roberts, M. C., Vernberg, E. M., & Randall, C. J. (2007) · Journal of Child and Family Studies · doi:10.1007/s10826-007-9162-1 · Cited by 11
Gayet‐Ageron, A., Agoritsas, T., Combescure, C., Bagaméry, K., Courvoisier, D. S., & Perneger, T. (2010) · BMC Medical Research Methodology · doi:10.1186/1471-2288-10-93 · Cited by 11
Aarabi, M., Skinner, J., Price, C. E., & Jackson, P. R. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282f07973 · Cited by 11
Qualifying Change: A Method for Defining Clinically Meaningful Outcomes of Change Score Computation
Tractenberg, R. E., Jin, S., Patterson, M. B., Schneider, L. S. S., Gamst, A. C., Thomas, R. G., & Thal, L. J. (2000) · Journal of the American Geriatrics Society · doi:10.1111/jgs.2000.48.11.1478 · Cited by 11
Hazell, P., Lewin, T. J., & Sly, K. A. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01581.x · Cited by 11
EFFECT SIZE AND POWER FOR CLINICAL TRIALS THAT MEASURE YEARS OF HEALTHY LIFE
Diehr, P. H., Psaty, B. M., & Patrick, D. L. (1997) · Statistics in Medicine · Cited by 11
Holmbäck, A. M., & Lexell, J. E. (2007) · Isokinetics and Exercise Science · doi:10.3233/ies-2007-0282 · Cited by 10
Grooten, W. J. A., Puttemans, V., & Larsson, R. J. M. (2002) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1034/j.1600-0838.2002.00142.x · Cited by 10
Rejas, J., de Miguel, Á. G., Isidro, C. S., Palacios, G., & Carrasco‐Garrido, P. (2005) · Medicina Clínica · doi:10.1157/13071490 · Cited by 10
Zangger, P., Kachura, J. R., Bombardier, C., Redelmeier, D. A., Badley, E. M., & Bogoch, E. R. (2003) · Joint Bone Spine · doi:10.1016/j.jbspin.2003.07.009 · Cited by 10
Enhancing toxicity test performance by using a statistical criterion
Denton, D. L., Fox, J. F., & Fulk, F. (2003) · Environmental Toxicology and Chemistry · doi:10.1897/02-384 · Cited by 10
Validation of the sleep impact scale in patients with major depressive disorder and insomnia
Lasch, K., Joish, V. N., Zhu, Y., Rosa, K., Qiu, C., & Crawford, B. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902973201 · Cited by 10
Bohannon, R. W. (2009) · Isokinetics and Exercise Science · doi:10.3233/ies-2009-0349 · Cited by 9
Pandina, G., Garibaldi, G., Revicki, D., Kleinman, L., Turkoz, I., Kujawa, M., & Mahmoud, R. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283320667 · Cited by 9
Prévalence de la dépression dans la sclérose en plaques. Revue et méta-analyse
EVEN, C., Friedman, S., Dardennes, R. M., Zuber, M., & Guelfi, J. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)71073-5 · Cited by 9
Hvidsten, K., Carlsson, M. O., Stecher, V. J., Symonds, T. L., & Levinson, I. P. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.47 · Cited by 9
Responsiveness of Outcome Measures Used in an Antidementia Drug Trial
Rockwood, K. J., & Stolee, P. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200007000-00010 · Cited by 9
Stull, D. E., Vernon, M., Canonica, G. W., Crespi, S., & Sandor, D. W. (2008) · Allergy and Asthma Proceedings · doi:10.2500/aap.2008.29.3119 · Cited by 9
Kuźniar, T. J., Patkowski, J., Liebhart, J., Wytrychowski, K., Dobek, R., Ślusarz, R., Liebhart, E. H., & Małolepszy, J. (1999) · PubMed · Cited by 9
A simple method for calculating power based on a prior trial
Borm, G. F., Bloem, B. R., Munneke, M., & Teerenstra, S. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.10.011 · Cited by 8
The Minimal Clinically Important Difference of the Carpal Tunnel Syndrome Symptom Severity Scale
Rider, D. A. (2007) · Journal of Hand Therapy · doi:10.1197/j.jht.2007.04.013 · Cited by 8
A Simple Model to Predict the Sensitivity to Change of Visual Acuity Measurements
Cousens, S., Rosser, D. A., Murdoch, I., & Laidlaw, D. A. H. (2004) · Optometry and Vision Science · doi:10.1097/01.opx.0000144745.42600.76 · Cited by 8
Responsiveness of the physical mobility scale in long-term care facility residents.
Pike, E., & Landers, M. R. (2010) · PubMed · Cited by 8
Variability of Spirometry in Chronic Obstructive Pulmonary Disease: Results from Two Clinical Trials
MAURER, J. R. (2008) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)70590-5 · Cited by 8
Estimation of Clinical Significance: A Brief Note
Horton, A. M. (1980) · Psychological Reports · doi:10.2466/pr0.1980.47.1.141 · Cited by 8
Bruynesteyn, K., van der Linden, S., Landewé, R., Gubler, F. M., Weijers, R. E., & van der Heijde, D. M. F. M. (2004) · PubMed · Cited by 8
Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
(2012) · Clinical Governance An International Journal · doi:10.1108/cgij.2012.24817daa.010 · Cited by 8
Measuring physicians' judgment--the use of clinical data by Australian rheumatologists.
Kirwan, J., Currey, H. L. F., & Brooks, P. (1985) · PubMed · Cited by 7
Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005) · Hepatology · doi:10.1002/hep.20659 · Cited by 7
Définition de l’état aigu dans la schizophrénie : enquête réalisée auprès des psychiatres français
Bayle, F., Misdrahi, D., Llorca, P., Lançon, C., Olivier, V., Quintin, P., & Azorin, J. (2005) · L Encéphale · doi:10.1016/s0013-7006(05)82367-x · Cited by 7
Effect Size: Utility and Application in Neuroscience Nursing
Winkelman, C. (2001) · Journal of Neuroscience Nursing · doi:10.1097/01376517-200108000-00008 · Cited by 7
Comparison of quality of life measures in heart failure
Adams, J. (2003) · Nursing Older People · doi:10.7748/nop.15.7.8.s7 · Cited by 7
140. A validated disease severity scoring system for Fabry disease
Waldek, S., Giannini, E. H., Mehta, A. B., Hilz, M. J., Beck, M., Bichet, D. G., Brady, R. O., West, M. E. D., Germain, D. P., Wanner, C., et al. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.10.157 · Cited by 7
Kraak, M. H. S., Wijnands, P., Govers, H. A. J., Admiraal, W. A., & de Voogt, P. (1997) · Environmental Toxicology and Chemistry · doi:10.1897/1551-5028(1997)016<1970:atasar>2.3.co;2 · Cited by 7
Wang, Q., Denton, D. L., & Shukla, R. (2000) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620190113 · Cited by 7
Bridges, T. S., & Farrar, J. D. (1997) · Environmental Toxicology and Chemistry · Cited by 7
Duru, G., & Fantino, B. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.01.477 · Cited by 6
Girling, A. J., Lilford, R. J., Braunholtz, D., & Gillett, W. R. (2007) · Clinical Trials · doi:10.1177/1740774506075872 · Cited by 6
Burton, H. J., Kline, S. A., Cooper, B. S., Rabinowitz, A., & Dodek, A. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(03)00016-1 · Cited by 6
Assessing clinically relevant cognitive decline: preliminary data on a new method
Isella, V., Atzeni, L., Iurlaro, S., Villa, M. L., Russo, A., Forapani, E., Frattola, L., & Appollonio, I. M. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0146-7 · Cited by 6
Wong, R. K. S., Gafni, A., Whelan, T. J., Franssen, E., & Fung, K. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02995-4 · Cited by 6
McKinnon, A. D., Bowyer, S. M., Hubbard, C. W., Miley, H. S., Perkins, R. W., Thompson, R. C., & Warner, R. A. (1998) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/bf02385947 · Cited by 6
How physicians use laboratory tests
Skendzel, L. P. (1978) · JAMA · doi:10.1001/jama.239.11.1077 · Cited by 6
(2008) · Primary Health Care · doi:10.7748/phc.18.4.24.s23 · Cited by 6
Psychometric properties of the functional rating index in patients with low back pain
Childs, J. D., & Piva, S. R. (2005) · European Spine Journal · doi:10.1007/s00586-005-1038-8 · Cited by 6
DEFINING CLINICALLY SIGNIFICANT CHANGES IN THE TREATMENT OF CHILD STUTTERERS
Gagnon, M., & Ladouceur, R. (1991) · Perceptual and Motor Skills · doi:10.2466/pms.1991.73.2.375 · Cited by 6
Chiou, C., Sherbourne, C. D., Cornelio, I., Lubeck, D. P., Paulus, H. E., Dylan, M. L., & Weisman, M. H. (2006) · PubMed · Cited by 5
Patient Defined Dichotomous End Points for Remission and Clinical Improvement in Ulcerative Colitis
Lichtenstein, G. R. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70354-4 · Cited by 5
Clinical significance in the change of decline in ALSFRS-R
Castrillo‐Viguera, C., Grasso, D., Simpson, E., Shefner, J. M., & Cudkowicz, M. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960903093710 · Cited by 5
ASSESSING CLINICALLY SIGNIFICANT CHANGE: APPLICATION TO THE SCL-90-R
Schmitz, N. (2000) · Psychological Reports · doi:10.2466/pr0.86.1.263-274 · Cited by 5
VARIATION, REPLICATION, AND POWER ANALYSIS OF MYRIOPHYLLUM SPP. MICROCOSM TOXICITY DATA
Hanson, M. L., Sanderson, H., & Solomon, K. R. (2003) · Environmental Toxicology and Chemistry · Cited by 5
Effects of sporophyll storage on giant kelp Macrocystis pyrifera (Agardh) bioassay
Gully, J. R., Bottomley, J. P., & Baird, R. B. (1999) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620180719 · Cited by 4
A survey of physician efficacy requirements to plan clinical trials
Oremus, M., Collet, J., Corcos, J., & Shapiro, S. H. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.750 · Cited by 4
Thomas, K. M., Ruby, J., Peter, J. V., & Cherian, A. M. (1995) · PubMed · Cited by 4
(2010) · Taylor & Francis eBooks · doi:10.4324/9780203448304_chapter_10 · Cited by 4
Lauridsen, H. H., Hartvigsen, J., Manniche, C., Korsholm, L., & Grunnet-Nilsson, N. (2006) · European Spine Journal · doi:10.1007/s00586-006-0260-3 · Cited by 4
Interpreting Results in Mental Health Research
Harman, J. S., Manning, W. G., Lurie, N., & Liu, C. (2001) · Mental Health Services Research · doi:10.1023/a:1011564918552 · Cited by 3
A Study of Minimal Change in Nocturia Affecting Quality of Life
Shim, J.-B., Lee, S. H., & Kim, H. (2009) · Korean journal of urology · doi:10.4111/kju.2009.50.3.241 · Cited by 3
Unilateral and bilateral electroconvulsive therapy: what informs Scottish psychiatrists' choices?
Brown, K. A. (2009) · Psychiatric Bulletin · doi:10.1192/pb.bp.107.018853 · Cited by 3
Anderson, B. S., Hunt, J. W., Phillips, B. M., Tudor, S., Fairey, R., Newman, J. W. I., Puckett, H. M., Stephenson, M., Long, E. R., & Tjeerdema, R. S. (1998) · Environmental Toxicology and Chemistry · doi:10.1897/1551-5028(1998)017 · Cited by 3
Anderson, B. S., Hunt, J. W., Phillips, B. M., Tudor, S., Fairey, R., Newman, J. W. I., Puckett, H. M., Stephenson, M., Long, E. R., & Tjeerdema, R. S. (1998) · Environmental Toxicology and Chemistry · Cited by 3
REPEATABILITY AND RELIABILITY OF A NEW THERMOTACTILE QUANTITATIVE SENSORY TESTING ALGORITHM
Klopčič, M., & Jakovljević, M. (2009) · Slovenian Medical Journal · Cited by 2
Rejas, J., Ruiz, M. Á., & Pardo, A. (2007) · Anales de Medicina Interna · doi:10.4321/s0212-71992007000900002 · Cited by 2
Guidance on minimally important clinical difference and trial size is needed
Cook, J. A., Ramsay, C. R., Vale, L. D., & On behalf of the DELTA project group (2011) · BMJ · doi:10.1136/bmj.d4375 · Cited by 2
Self-citationLittlewood, T. J. (2005) · Current Medical Research and Opinion · doi:10.1185/174234305x13770 · Cited by 2
Response criteria for cutaneous SLE in clincal trials
Mosca, M., Liang, M. H., Albrecht, J., Bombardieri, S., Buyon, J. P., Cervera, R., Fischer‐Betz, R., Gall, V., Gladman, D. D., Hunzelman, N., et al. (2007) · Cited by 2
Introduction to Randomized Controlled Trials
Glewwe, P. W., & Todd, P. (2022) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-1497-6_ch6 · Cited by 2
Samsa, G. P., & Matchar, D. B. (2001) · Stroke · doi:10.1161/str.32.suppl_1.373 · Cited by 2
Massel, D. R., & Cruickshank, M. K. (2000) · Cancer Investigation · doi:10.3109/07357900009012213 · Cited by 1
Chen, H. Y., Hung, Y. C., Yang, T. C., Yeh, L. S., & Chang, W. C. (2006) · Zhōngtáiwān yīxué kēxué zázhì · doi:10.6558/mtjm.2006.11(4).3 · Cited by 1
Quantification of a Meaningful Change in Low Back Functional Impairment
Huddleston, P. M. (2010) · Yearbook of Orthopedics · doi:10.1016/s0276-1092(10)79711-x · Cited by 1
DEFINING CLINICALLY SIGNIFICANT CHANGES IN THE TREATMENT OF CHILD STUTTERERS
Gagnon, M. (1991) · Perceptual and Motor Skills · doi:10.2466/pms.73.5.375-378 · Cited by 1
Desmond, D. W., Tatemichi, T. K., Stern, Y., & Sano, M. C. (1995) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(95)00002-l · Cited by 1
Hazell, P., Lewin, T. J., & Sly, K. A. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2005.01581.x · Cited by 1
EFFECTS OF SPOROPHYLL STORAGE ON GIANT KELP MACROCYSTIS PYRIFERA (AGARDH) BIOASSAY
Gully, J. R., Bottomley, J. P., & Baird, R. B. (1999) · Environmental Toxicology and Chemistry · Cited by 1
A simple method for converting an odds ratio to effect size for use in meta-analysis
Chinn, S. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001130)19:22<3127::aid-sim784>3.0.co;2-m
(2001) · doi:10.1002/1529-0131(200108)45:4<384::aid-art352>3.0.co;2-0
Cited by
Lakens, D. (2022) · Collabra Psychology · doi:10.1525/collabra.33267 · Cited by 1,962
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Self-citationVitamin D supplementation for women during pregnancy
De-Regil, L. M., Palacios, C., Lombardo, L. K., & Peña-Rosas, J. P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008873.pub3 · Cited by 744
Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension
Butcher, N. J., Monsour, A., Mew, E. J., Chan, A.-W., Moher, D., Mayo-Wilson, E., Terwee, C. B., Chee-A-Tow, A., Baba, A., Gavin, F., et al. (2022) · JAMA · doi:10.1001/jama.2022.21022 · Cited by 719
“Minor variants of the term, such as minimum instead of minimal, or the addition of the adjective clinically or clinical are common (eg, the minimum clinically important change).(23)”
BackgroundMonitoring Fatigue Status in Elite Team-Sport Athletes: Implications for Practice
Thorpe, R. T., Atkinson, G., Drust, B., & Gregson, W. (2017) · International Journal of Sports Physiology and Performance · doi:10.1123/ijspp.2016-0434 · Cited by 328
Metadata
- Authors
- Cook, J., Hislop, J., Adewuyi, T., Harrild, K., Altman, D., Ramsay, C., Fraser, C., Buckley, B., Fayers, P., Harvey, I., Briggs, A., Norrie, J., Fergusson, D., Ford, I., & Vale, L.
- Affiliations
- University of Aberdeen (GB)
- University of Oxford (GB)
- Ollscoil na Gaillimhe – University of Galway (IE)
- University of East Anglia (GB)
- University of Glasgow (GB)
- Ottawa Hospital Research Institute (CA)
- Newcastle University (GB)
- ORCID
- Venue
- Health Technology Assessment
- Published
- 2014-01
- Volume
- 18
- Issue
- 28
- Pages
- v-vi, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- PMC
- PMC4781097
- OpenAlex
- W2171723063
- Cited by
- 194
- References
- 871
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 19 · 2020: 18 · 2019: 14 · 2018: 24 · 2017: 25 · 2016: 27 · 2015: 33 · 2014: 3
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc-nd)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Galway Research Repository (submittedVersion, cc-by-nc)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Research Repository UCD (University College Dublin) (cc-by-nc)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health Research
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- sample size determination, randomized controlled trials, trial design, clinical trial design, DELTA project, health interventions, research capacity building
- MeSH terms
- Attitude of Health Personnel, Cost-Benefit Analysis, Data Collection, United Kingdom, Humans, Ireland, Research Personnel, Societies, Scientific, Statistics as Topic, Epidemiologic Research Design, Bias, Randomized Controlled Trials as Topic, Patient Satisfaction, Sample Size, Evidence-Based Medicine, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.